| Nov 14 |
BerGenBio ASA (FRA:7BG0) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst Leadership ...
|
| Nov 9 |
ADC Therapeutics SA (ADCT) Q3 2024 Earnings Call Transcript
|
| Nov 9 |
ADC Therapeutics Third Quarter 2024 Earnings: EPS Misses Expectations
|
| Nov 8 |
ADC Therapeutics Faces Competitive Oncology Market But Analyst Sees 100% Upside - Here's Why
|
| Nov 7 |
ADC Therapeutics SA (ADCT) Reports Q3 Loss, Lags Revenue Estimates
|
| Nov 7 |
ADC Therapeutics Non-GAAP EPS of -$0.28, revenue of $18.46M misses by $0.04M
|
| Nov 7 |
ADC Therapeutics Reports Third Quarter and Year-to-Date 2024 Financial Results and Provides Operational Update
|
| Nov 6 |
Amicus Therapeutics (FOLD) Q3 Earnings and Revenues Beat Estimates
|
| Nov 5 |
ADC Therapeutics Announces Investigator-Initiated Study Abstracts Accepted for Presentation at the 66th ASH Annual Meeting
|
| Nov 4 |
ADC Therapeutics to Present at November Investor Conferences
|
